Get the Stockscreener App
9.33
1.06%
-0.12
Anavex Life Sciences Corporation stock is traded at $9.33, with a volume of 23,307.
It is down -1.06% in the last 24 hours and down -1.66% over the past month.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
See More
Previous Close:
$9.45
Open:
$9.46
24h Volume:
23,307
Relative Volume:
0.02
Market Cap:
$761.32M
Revenue:
-
Net Income/Loss:
$-43.16M
P/E Ratio:
-16.96
EPS:
-0.55
Net Cash Flow:
$-29.31M
1W Performance:
+5.59%
1M Performance:
-1.66%
6M Performance:
+77.30%
1Y Performance:
+177.13%
1-Day Range:
$9.32
$9.50
1-Week Range:
$8.61
$9.80
52-Week Range:
$3.25
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corporation
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
9.32 | 761.32M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
487.51 | 125.74B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.74 | 61.57B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.12 | 36.40B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.76 | 30.36B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
247.67 | 24.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corporation Stock (AVXL) Latest News
Anavex Life Sciences Corporation’s Market Journey: Closing Strong at 9.31, Up 1.09 - DWinneX
Buying Buzz: Anavex Life Sciences Corporation [AVXL] Director Donhauser Peter D.O. purchases 2,835 shares of the company – Knox Daily - knoxdaily.com
AVXL overperforms with a 5.14 increase in share price - uspostnews.com
Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board - The Manila Times
Harvard-Trained Alzheimer's Pioneer With 35,000-Patient Database Strengthens Anavex's Scientific Team - Stock Titan
Anavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ... - Yahoo Finance
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by LPL Financial LLC - Defense World
Anavex Life Sciences Presents Novel Alzheimer Treatment Research at International Conference in Abu Dhabi - Nasdaq
Anavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East - TradingView
Geode Capital Management LLC Has $20.14 Million Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Holdings Raised by Alliancebernstein L.P. - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences LawsuitAVXL - ACCESS Newswire
Anavex Stock Jumps Pre-Market After Submitting Oral Alzheimer's Drug To European Regulators For Approval: Retail Over The Moon - MSN
Wellington Management Group LLP Makes New $1.70 Million Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Prudential Financial Inc. Acquires Shares of 10,160 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Vanguard Group Inc. Sells 59,727 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Corebridge Financial Inc. Trims Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Biotech Company Finds High-Impact Alzheimer's Therapy in Europe - streetwisereports.com
Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at HC Wainwright - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at D. Boral Capital - Defense World
Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years - Benzinga
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease - The Manila Times
Breakthrough: New Alzheimer's Drug Cuts Cognitive Decline Over 4 Years in Clinical Trial - Stock Titan
Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Anavex Life Sciences Corporation (AVXL)May 13, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact Levi & Korsinsky about pending Class ActionAVXL - ACCESS Newswire
AVXL’s price-to-free cash flow ratio: What it means for investors - uspostnews.com
Commonwealth Equity Services LLC Buys 7,285 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Given “Buy” Rating at HC Wainwright - Defense World
Anavex Life Sciences to Present at the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
Anavex Showcases Breakthrough CNS Therapies: CEO Details Pipeline at Major Healthcare Conference - Stock Titan
Heartland Advisors Inc. Takes Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - MarketBeat
19,558 Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) Acquired by Proficio Capital Partners LLC - Defense World
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 3.2%Here's Why - MarketBeat
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Purchased by Intech Investment Management LLC - The AM Reporter
Charles Schwab Investment Management Inc. Purchases 11,239 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Bank of New York Mellon Corp Has $2.37 Million Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL - Business Wire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Atria Investments Inc - Defense World
Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus - TradingView
Proficio Capital Partners LLC Purchases New Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Did Anavex Life Sciences Corp. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- AVXL - ACCESS Newswire
Anavex Life Sciences Corp. to Host Earnings Call - ACCESS Newswire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stake Raised by Rhumbline Advisers - Defense World
Private Advisor Group LLC Sells 17,488 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
IMMINENT AVXL DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Anavex Life Sciences Corp. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Y Intercept Hong Kong Ltd Makes New $243,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corporation Sued for Securities Law ViolationsContact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 – AVXL - ACCESS Newswire
Anavex Life Sciences Corporation Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Anavex Life Sciences Corporation Stock (AVXL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Donhauser Peter D.O. | Director |
Jun 14 '24 |
Buy |
3.64 |
2,835 |
10,319 |
5,000 |
| Thomas Steffen | Director |
May 15 '24 |
Buy |
4.52 |
5,000 |
22,600 |
5,000 |
0.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):